
What We’re Reading: School Nurse Shortage; Keytruda Receives FDA Expansion; Menthol Cigarette, Flavored Cigar Ban
School nurses play an overworked and understaffed role; Merck's immunotherapy Keytruda (pembroilzumab) has been granted approval for pre- and postsurgical treatment in lung cancer; the FDA is helping to curb tobacco-related health disparities.
School Nurses Struggle to Keep Students Healthy
School nurses are often the frontline for public health concerns in schools, including tracking vaccinations and addressing sensitive topics with parents,
FDA Expands Keytruda's Use in Early-Stage NSCLC
The FDA has granted approval for the extended use of Merck & Co's immunotherapy drug, Keytruda (pembrolizumab), in patients who have early-stage non–small cell
FDA Proposes Ban on Menthol Cigarettes, Flavored Cigars
The FDA has taken a significant step toward banning menthol in cigarettes and flavored cigars, a move that public health experts believe could save hundreds of thousands of lives,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.